“The Vaccine War” film has created a significant buzz in the media and among the public since its release in theaters. This film is not just a movie; it’s a tribute to the unconquerable spirit of Indian scientists and a revelation of the challenges they faced during the COVID-19 pandemic. OTT Launch of ‘The Vaccine ...

 There is no increased risk of blood clotting post vaccination with Covaxin and Covishield so far, ruled top government committee. The top committee came to the finding post analyzing more than 400 adverse reactions encountered during ongoing vaccination drive in India.  Dr NK Arora, executive director of the INCLEN Trust and an advisor to the ...

With 1 million COVID-19 shots in just 6 days, India’s vaccination drive becomes the world’s fastest The Indian government has vaccinated nearly 16 lakh people against COVID-19 since the launch of its mass inoculation drive on January 16. According to the Health Ministry, authorities have administered approximately 10 lakh vaccine shots in just six days, ...

Individuals who are on medication that affects their immune system are advised not to take Covaxin, the developer Bharat Biotech cautioned on Monday via a factsheet. The company strongly urged people to reveal to their immunization officers about any serious health-related conditions or allergies before getting the jab.  Bharat Biotech stated that people who are ...

Covid-19 vaccination drive: January 16 will mark commencement of one of the biggest vaccination drives in India. The Covid-19 vaccination drive will be launched across India at around 3000 sites, with the number scheduled to increase to up to 5000 by end of this month. This number is further expected to ramp up by March ...

Indian Vaccine: The Covaxin vaccine is getting embroiled in domestic skirmish even before its delivery schedules have been put into place. The bone of contention is the fact that the vaccine has been granted emergency approval even before the human trials were completed.  There is communal disharmony over the contents of the vaccine. The main ...

Covaxin phase 1 trials: Results of phase 1 trials of Covaxin vaccine were released in a preprint paper “A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine -BBV152”. Preprint paper is a scientific manuscript version which is posted on public server before formal peer review.  The vaccine’s results propose the Covid-19 vaccine ...

India’s vaccination strategy: As the number of Coronavirus cases continues to surge across various states in India, Prime Minister Narendra Modi on Friday held a virtual meeting with top officials to review the vaccination strategy of the country and efforts needed to make the vaccine accessible to the public. Taking to Twitter, PM Modi stated ...

Phase III clinical trials: Hyderabad based pharma giant, Bharat Biotech has announced of beginning phase III clinical trials of India’s first indigenous Covid-19 vaccine, COVAXIN. This phase will include 26,000 volunteers across 25 centres in India and is to be conducted in collaboration with the ICMR (Indian Council of Medical Research). This will make COVAXIN ...

A highly anticipated Covid-19 vaccine, COVAXIN, is being developed by Hyderabad-based Bharat Biotech in collaboration with ICMR (Indian Council of Medical Research). ICMR officials have said that the vaccine that was earlier being projected to launch only be second quarter of 2021, can now be hoped to be launched as early as February.  This is ...